Onderneming Sarepta Therapeutics, Inc. Sao Paulo
Aandelen
S1RP34
BRS1RPBDR005
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
44,61 BRL | +33,12% |
|
+35,26% | +94,29% |
21/06 | Sectorupdate: Gezondheidszorgaandelen winnen in de late namiddag | MT |
21/06 | S&P, Nasdaq dalen als Nvidia voor tweede dag daalt | RE |
Vakgebied
Aantal werknemers: 1 314
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26-06-17 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 01-01-15 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 48 | 01-06-18 | |
Will Tilton
HRO | Human Resources Officer | - | - |
Alison Nasisi
HRO | Human Resources Officer | - | - |
Dallan Murray
PRN | Corporate Officer/Principal | - | 01-01-13 |
Diane Berry
PRN | Corporate Officer/Principal | - | 01-12-11 |
Ryan Brown
LAW | General Counsel | 46 | 01-01-18 |
Joseph Bratica
AUD | Comptroller/Controller/Auditor | 60 | 01-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26-06-17 |
M. Wilsey
CHM | Chairman | 71 | 31-03-09 |
Richard Barry
BRD | Director/Board Member | 65 | 02-06-15 |
Director/Board Member | 86 | 01-06-10 | |
Stephen Mayo
BRD | Director/Board Member | 62 | 16-11-21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 02-06-15 |
Michael Chambers
BRD | Director/Board Member | - | 02-06-22 |
Kathryn Boor
BRD | Director/Board Member | 65 | 02-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 94 523 766 | 89 825 408 ( 95,03 %) | 0 | 95,03 % |
Bedrijfsgegevens
Sarepta Therapeutics, Inc.
215 First Street Suite 415
02142, Cambridge
+617 274 4000
http://www.sareptatherapeutics.com![Adres Sarepta Therapeutics, Inc.(S1RP34)](https://cdn.zonebourse.com/static/address/119084116.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,19% | 121 mld. | |
+19,91% | 114 mld. | |
-19,80% | 20,43 mld. | |
-16,19% | 16,55 mld. | |
-13,45% | 16,45 mld. | |
-44,35% | 15,59 mld. | |
+2,13% | 13,54 mld. | |
+119,39% | 10,96 mld. | |
+19,33% | 8,15 mld. |
- Beurs
- Aandelen
- Koers SRPT
- Koers S1RP34
- Onderneming Sarepta Therapeutics, Inc.